Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study.
Nakase H, Fujii T, Hisamatsu T, Suzuki Y, Watanabe M, Takahashi S, Ooi M, Takeuchi K, Kimura T, Furuya K, Aoyama N, Hasatani K, Horiki N, Kanke K, Tokito S, Sai S, Uchikawa Y, Goto S, Fujimoto G, Zhang C, Petersen A, Hibi T.
Nakase H, et al. Among authors: kanke k.
Gastro Hep Adv. 2025 Sep 16;5(1):100812. doi: 10.1016/j.gastha.2025.100812. eCollection 2026.
Gastro Hep Adv. 2025.
PMID: 41281463
Free PMC article.